In this survey, the major indications for HBO2 therapy were consciousness disturbance upon arrival, exposure to CO for a long time, and elevated arterial CO-Hb, whereas at 24% of institutions, HBO2 therapy was administered to all patients diagnosed with CO poisoning. This evidence concerns the gene GSTM1 and poisoning.